Veterinary Vaccines Information and Analysis with forecast growth: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026

"Veterinary Vaccines Market: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Attenuated live vaccines are expected to emerge as the dominant vaccine type segment over the forecast period

Attenuated live vaccines segment is the largest segment among the vaccine type segments, which was estimated to create close to US$ 90 Mn, or more than 30% share of the total market in 2016. By the end of 2026, attenuated live vaccines segment is projected to reach more than US$ 150 Mn, expanding at a CAGR of 5.8% over the forecast period. Greater adoption of live attenuated vaccines is expected to contribute to the attractive absolute $ opportunity of the segment. Attenuated live vaccines segment is expected to be the most lucrative in the MEA veterinary vaccines market with a market attractiveness index of 2.0.

Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=1287892

Rising incidence of food borne and zoonotic diseases in MEA countries likely to fuel the demand for attenuated live vaccines

Rising incidence of food borne and zoonotic diseases in MEA countries is fuelling the demand in the attenuated live vaccines segment in the region. As the pattern of veterinary treatment is shifting from curative/reactive to preventive, the cost of a preventive treatment is much smaller and has far less side effects than reactive treatments that often lead to mass slaughter. This is the precise reason behind driving the growth of the attenuated live vaccines segment in the MEA region. Rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This demands effective vaccination of livestock, especially in major animal farming and meat producing nations with a diversified herd in the region such as Sudan, Turkey, Egypt and KSA. Rising per capita disposable income levels are largely contributing to the rise in demand for processed food items. This is expected to drive the growth in demand for attenuated live vaccines in the poultry and livestock segments.

There are international guidelines on the usage of livestock identification and traceability systems (LITS) for better herd management, identifying zoonosis and managing animal health and incorporating food safety. However, most countries in the MEA region fail to implement proper LITS thereby affecting effective animal disease management. This is expected to fuel the demand for protective maintenance of animal health through early attenuated live vaccinations in order to avoid the spread of infectious diseases. The countries within the MEA region and Central Europe are increasingly dependent on live stock trading as a means of survival. Furthermore, in order to address chronic food insecurity in rural areas, animals are transferred from one place to another. This is fuelling demand for adequate vaccinations as an infection affecting one of the herds could easily spread to another and lead to mass losses. This factor is creating a positive impact on attenuated live vaccinations in the region.

Attenuated live vaccines are expected to witness increased demand throughout the forecast period in Jordan

The attenuated live vaccines segment is expected to witness a significant CAGR given greater adoption in commercial farms in the UAE veterinary vaccines market. Lower dosages and repetition are factors that are expected to contribute towards greater demand for attenuated live vaccines among all animal segments in Turkey. In Jordan, attenuated live vaccines are expected to witness increased demand throughout the forecast period. Lack of organised animal rearing and tracking practices hinder estimation of demand for attenuated live vaccines in Sudan.

Scenario of Local Manufacturing and Veterinary Vaccine Registration

The MEA region accounts for a vast livestock population; however, it is largely dependent on imports for the supply of adequate veterinary vaccines. Only six countries have the facility to produce vaccines locally. These include Egypt, Jordan, Saudi Arabia, Sudan, Syria and Turkey. Local produce acceptance is higher as regulatory authorities have relatively fewer requirements for local vaccines than imported ones. The time duration for imported vaccines to obtain the required registration is also longer. Only four countries follow the international norms of OIE although the OIE has not yet established official international standards in this respect.

--- Analyst Healthcare, Pharmaceuticals and Medical Devices, Future Market Insights

Table Of Content

1. Executive Summary

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Parent / Associated Market Overview

3. Middle East Veterinary Vaccines Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain

4. Market Dynamics and USPs
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5.Standard Approval Process U.S.
4.6.Vaccines Labelling Requirements
4.7.Scenario of Local Manufacturing and Veterinary Vaccine Registration
4.8.Veterinary Medical Product Registration Timelines and Products

5. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Vaccine Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Vaccine Type
5.3. Y-o-Y Growth Projections By Vaccine Type
5.4. Market Value Forecast By Vaccine Type, 20162026
5.4.1. Live Attenuated Vaccines
5.4.2. Killed/Inactive Vaccines
5.4.3. Recombinant Vaccines
5.4.4. DNA Vaccines
5.4.5. Toxoid Vaccines
5.4.6. Others
5.5. Market Attractiveness By Vaccine Type

6. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Animal Type
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Animal Type
6.3. Y-o-Y Growth Projections By Animal Type
6.4. Market Value Forecast By Animal Type, 20162026
6.4.1. Companion Animal
6.4.1.1. Canine
6.4.1.2. Feline
6.4.1.3. Avian (Ornamental Bird)
6.4.2. Livestock Animal
6.4.2.1. Aquatic
6.4.2.2. Bovine
6.4.2.3. Porcine
6.4.2.4. Small Ruminant
6.4.2.5. Poultry
6.4.3. Equine
6.5. Market Attractiveness By Animal Type

7. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Disease Indication
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Disease Indication
7.3. Y-o-Y Growth Projections By Disease Indication
7.4. Market Value Forecast By Disease Indication, 20162026
7.4.1. Foot and Mouth Diseases
7.4.2. Avian Influenza

Full Report @ http://www.researchmoz.us/veterinary-vaccines-market.html

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.